Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
BBBIOCB:LX
459.89
CHF
6.19
1.33%
As of 08:42:00 ET on 07/27/2015.
Fund Type
SICAV
52Wk Range
292.34 - 494.89
1 Yr Return
56.68%
YTD Return
15.91%
Previous Close
466.08
52Wk Range
292.34 - 494.89
1 Yr Return
56.68%
YTD Return
15.91%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/27/2015)
459.89
Total Assets (m USD) (on 07/27/2015)
106.368
Inception Date
04/02/2009
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
CHRISTIAN LACH
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
2.40%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 20.00 k 8.08 m 7.89
Gilead Sciences Inc 68.00 k 7.96 m 7.78
Regeneron Pharmaceuticals Inc 14.40 k 7.35 m 7.18
Celgene Corp 63.00 k 7.29 m 7.12
Amgen Inc 30.87 k 4.74 m 4.63
Alexion Pharmaceuticals Inc 20.75 k 3.75 m 3.66
Mylan NV 55.00 k 3.73 m 3.65
Vertex Pharmaceuticals Inc 28.50 k 3.52 m 3.44
BioMarin Pharmaceutical Inc 25.00 k 3.42 m 3.34
Illumina Inc 15.56 k 3.40 m 3.32
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00